Condition

Relapsed Hematologic Malignancy (7)

Refractory Hematologic Malignancy (3)

Advanced or Metastatic Solid Tumor (1)

Multiple Myeloma (1)

Overall Status

Recruiting (5)

Completed (1)

Not yet recruiting (1)

Phase

n/a (2)

phase 1/phase 2 (2)

Sponsor

A.O. Ospedale Papa Giovanni XXIII (1)

Curis, Inc. (1)

Institut Cancerologie de l'Ouest (1)

Medical University of Vienna (1)

Pack Health (1)

Princess Maxima Center for Pediatric Oncology (1)

St. Jude Children's Research Hospital (1)

Collaborator

GlaxoSmithKline (1)

University of Washington (1)

Intervention

advice (1)

digital health coaching program (1)

donor-derived cik cells (1)

emavusertib (1)

fitbit (1)

ibrutinib (1)

ippactto (1)

ngfds selected treatment (1)

Study Documents

Intervention Type

behavioral (2)

drug (2)

biological (1)

device (1)

other (1)

Funder Type

Other (5)

Industry (2)

Study Type

Interventional (4)

Observational (3)

relapsed hematologic malignancy

Showing 1 - 7 of 7

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Multiple Myeloma, Relapsed Hematologic Malignancy Trial in Seattle (Digital Health Coaching Program, Fitbit)

Recruiting

Multiple Myeloma
Relapsed Hematologic Malignancy

Digital Health Coaching Program
Fitbit

Seattle, Washington

University of Washington

Jul 13, 2023

After Adoptive Transfer of Genetically Modified Cell Products

Recruiting

Relapsed Hematologic Malignancy
Refractory Hematologic Malignancy

Memphis, Tennessee

St. Jude Children's Research Hospital

Feb 6, 2023